What is Barclays's price target for DD?

Barclays's latest stated price target for DuPont de Nemours Inc. (DD) is $156, from its action on Oct 13, 2026.

What is Barclays's rating on DD?

Barclays rates DD Overweight, a bullish rating, as of Oct 13, 2026.

When did Barclays last change its view on DD?

On Oct 13, 2026, Barclays starts coverage at Overweight, price target $156.

Barclays DD price target and rating history

DuPont de Nemours Inc. (DD) · Industrials

Barclays rates DuPont de Nemours Inc. (DD) Overweight with a $156 price target, as of its latest action on Oct 13, 2026. It has published 4 rating actions on DD since February 2022, including 1 upgrade and 1 downgrade.

Current rating: Overweight
Price target: $156
Median target, all firms: Too few
Actions on DD: 4

Barclays price target on DD

Barclays price target on DD, each point a stated target, February 2022 to October 2026.

Every Barclays rating on DD

Oct 13, 2026
InitiateBarclays starts coverage at Overweight, price target $156
Feb 13, 2025
UpgradeBarclays upgrades to Equal Weight from Underweight, price target $85 to $89
Oct 7, 2024
DowngradeBarclays downgrades to Underweight from Equal Weight, price target $88 to $84
Feb 9, 2022
ReiterateBarclays raises its price target to $88 from $84, keeps Equal Weight

How other firms rate DD

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Barclays	Overweight	$156	Oct 13, 2026
Goldman Sachs	Neutral	$53	Jun 15, 2026

Questions about Barclays and DD

What is Barclays's price target for DD?: Barclays's latest stated price target for DuPont de Nemours Inc. (DD) is $156, from its action on Oct 13, 2026.
What is Barclays's rating on DD?: Barclays rates DD Overweight, a bullish rating, as of Oct 13, 2026.
When did Barclays last change its view on DD?: On Oct 13, 2026, Barclays starts coverage at Overweight, price target $156.

More DD rating histories

All Barclays ratings DD news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.